Haffner, M. C. Et Al. 2018. Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer. AMERICAN JOURNAL OF PATHOLOGY , vol.188, no.6 , 1478-1485.

Haffner, M. C., GÜNER, G., Taheri, D., Netto, G. J., Palsgrove, D. N., Zheng, Q., ... Guedes, L. B.(2018). Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer. AMERICAN JOURNAL OF PATHOLOGY , vol.188, no.6, 1478-1485.

Haffner, Michael Et Al. "Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer," AMERICAN JOURNAL OF PATHOLOGY , vol.188, no.6, 1478-1485, 2018

Haffner, Michael C. Et Al. "Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer." AMERICAN JOURNAL OF PATHOLOGY , vol.188, no.6, pp.1478-1485, 2018

Haffner, M. C. Et Al. (2018) . "Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer." AMERICAN JOURNAL OF PATHOLOGY , vol.188, no.6, pp.1478-1485.

@article{article, author={Michael C. Haffner Et Al. }, title={Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer}, journal={AMERICAN JOURNAL OF PATHOLOGY}, year=2018, pages={1478-1485} }